An Epidemiological Study to Describe Symptom Control and Impact of Gastroesophageal Reflux Disease
NCT ID: NCT01134367
Last Updated: 2011-07-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1000 participants
OBSERVATIONAL
2010-05-31
2010-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Symptom Control and Impact on Daily Life in Patients With Gastroesophageal Reflux Disease
NCT01432392
Symptoms and Management Strategies in Gastroesophageal Reflux Disease (GERD)
NCT00768443
The Study to Describe Symptom Control and Impact on Daily Life in Gastroesophageal Reflux Disease (GERD) Patients
NCT01200550
Impact of GERD on Daily Life (NIS)
NCT00545883
Survey to Describe Impact of Reflux Disease on Everyday Life in GERD Patients Before and After 4 Weeks Treatment.
NCT00786773
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Patients with GERD
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients should be treated for GERD according to current practice (National guideline for treatment of dyspepsia in GP setting)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
AstraZeneca
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Miodrag Krstić, Prof.Dr
Role: PRINCIPAL_INVESTIGATOR
Institute for Gastroenterology, Clinical Center of Serbia, Belgrade
Dragomir Damjanov, Prof. Dr
Role: PRINCIPAL_INVESTIGATOR
Clinic for Internal Diseases, Clinical Center of Vojvodina, Novi Sad
Aleksandar Nagorni, Prof. Dr
Role: PRINCIPAL_INVESTIGATOR
Clinic for Internal Diseases- Gastroenterology Dept, Clinical Center Nis
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Belgrade, , Serbia
Research Site
Leskovac, , Serbia
Research Site
Niš, , Serbia
Research Site
Novi Sad, , Serbia
Research Site
Pančevo, , Serbia
Research Site
Subotica, , Serbia
Research Site
Zrenjanin, , Serbia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIS-GRS-DUM-2010/1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.